Literature DB >> 1310628

Comparison of influenza A virus and formyl-methionyl-leucyl-phenylalanine activation of the human neutrophil.

K L Hartshorn1, D E Daigneault, M R White, M Tuvin, J L Tauber, A I Tauber.   

Abstract

Influenza A virus (IAV) activates the human neutrophil, but induces a dysfunctional state as well. Cell activation may contribute to the containment of the virus and/or cause local tissue damage. Certain features of the neutrophil activation response elicited by IAV are distinctive when compared with that triggered by formyl-methyl-leucyl-phenylalanine (FMLP). An atypical respiratory burst response occurs in which hydrogen peroxide, but no superoxide, is formed. This unusual respiratory burst stoichiometry persists despite marked priming of the IAV-induced response. A comprehensive examination of the activation cascade initiated by these stimuli failed to show an explanation for these differences. Both IAV and FMLP comparably stimulate inositol trisphosphate and phosphatidic acid production. The subsequent increase in intracellular calcium (Ca2+i) upon FMLP stimulation was more dependent on extracellular Ca2+ than with IAV activation, but both stimuli induced Ca2+ influx. FMLP and IAV exhibited equal susceptibility to inhibition by protein kinase inhibitors in eliciting the respiratory burst, and actin polymerization occurred in response to each agonist. A possible explanation for the anomalous respiratory burst induced by IAV is that O2- is generated at an intracellular site inaccessible to assay, and/or virus binding to sialic acid constituents of the plasma membrane alters the O2- generating capacity of the respiratory burst oxidase; evidence for each mechanism is offered.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310628

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Wheat germ agglutinin induces NADPH-oxidase activity in human neutrophils by interaction with mobilizable receptors.

Authors:  A Karlsson
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

2.  Human mannose-binding protein functions as an opsonin for influenza A viruses.

Authors:  K L Hartshorn; K Sastry; M R White; E M Anders; M Super; R A Ezekowitz; A I Tauber
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

Review 3.  Role of oxidants in microbial pathophysiology.

Authors:  R A Miller; B E Britigan
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

4.  Lower Respiratory Tract Infection of the Ferret by 2009 H1N1 Pandemic Influenza A Virus Triggers Biphasic, Systemic, and Local Recruitment of Neutrophils.

Authors:  Jeremy V Camp; Ulas Bagci; Yong-Kyu Chu; Brendan Squier; Mostafa Fraig; Silvia M Uriarte; Haixun Guo; Daniel J Mollura; Colleen B Jonsson
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

5.  Inhibition of MLC phosphorylation restricts replication of influenza virus--a mechanism of action for anti-influenza agents.

Authors:  Mehran Haidari; Wei Zhang; Leila Ganjehei; Muzammil Ali; Zhenping Chen
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

6.  Histone H4 potentiates neutrophil inflammatory responses to influenza A virus: Down-modulation by H4 binding to C-reactive protein and Surfactant protein D.

Authors:  I-Ni Hsieh; Mitchell White; Marloes Hoeksema; Xavier Deluna; Kevan Hartshorn
Journal:  PLoS One       Date:  2021-02-26       Impact factor: 3.240

7.  Screening differential miRNAs responsible for permeability increase in HUVECs infected with influenza A virus.

Authors:  Shujing Zhang; Ying Wu; Zinan Xuan; Xiaoming Chen; Junjie Zhang; Dongyu Ge; Xudan Wang
Journal:  PLoS One       Date:  2017-10-23       Impact factor: 3.240

8.  Histone H4 directly stimulates neutrophil activation through membrane permeabilization.

Authors:  I-Ni Hsieh; Xavier Deluna; Mitchell R White; Kevan L Hartshorn
Journal:  J Leukoc Biol       Date:  2020-08-17       Impact factor: 6.011

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.